HK1053316A1 - Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative - Google Patents
Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivativeInfo
- Publication number
- HK1053316A1 HK1053316A1 HK03105615A HK03105615A HK1053316A1 HK 1053316 A1 HK1053316 A1 HK 1053316A1 HK 03105615 A HK03105615 A HK 03105615A HK 03105615 A HK03105615 A HK 03105615A HK 1053316 A1 HK1053316 A1 HK 1053316A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- biotin
- polysaccharides
- covalent bond
- antithrombotic activity
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Polymers & Plastics (AREA)
- Materials Engineering (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Communicable Diseases (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Obesity (AREA)
- Oncology (AREA)
- Virology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0012094A FR2814463B1 (fr) | 2000-09-22 | 2000-09-22 | Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine |
| PCT/FR2001/002918 WO2002024754A1 (fr) | 2000-09-22 | 2001-09-20 | Polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1053316A1 true HK1053316A1 (en) | 2003-10-17 |
Family
ID=8854579
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK03105615A HK1053316A1 (en) | 2000-09-22 | 2003-08-05 | Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative |
Country Status (40)
| Country | Link |
|---|---|
| US (3) | US6844329B2 (is) |
| EP (1) | EP1322673B1 (is) |
| JP (2) | JP5016778B2 (is) |
| KR (2) | KR20080049139A (is) |
| CN (1) | CN1235914C (is) |
| AR (1) | AR030774A1 (is) |
| AT (1) | ATE374215T1 (is) |
| AU (2) | AU2001291960C1 (is) |
| BG (1) | BG66191B1 (is) |
| BR (1) | BR0114007A (is) |
| CA (1) | CA2418815C (is) |
| CY (1) | CY1108076T1 (is) |
| CZ (1) | CZ300856B6 (is) |
| DE (1) | DE60130669T2 (is) |
| DK (1) | DK1322673T3 (is) |
| EA (1) | EA005133B1 (is) |
| EC (1) | ECSP034514A (is) |
| EE (1) | EE05202B1 (is) |
| ES (1) | ES2292625T3 (is) |
| FR (1) | FR2814463B1 (is) |
| GE (1) | GEP20053616B (is) |
| HK (1) | HK1053316A1 (is) |
| HR (1) | HRP20030219B1 (is) |
| HU (2) | HUP0303551A3 (is) |
| IL (2) | IL154848A0 (is) |
| IS (1) | IS2550B (is) |
| ME (2) | ME00080B (is) |
| MX (1) | MXPA03002483A (is) |
| NO (2) | NO332905B1 (is) |
| NZ (1) | NZ524472A (is) |
| PE (1) | PE20020471A1 (is) |
| PL (1) | PL206727B1 (is) |
| PT (1) | PT1322673E (is) |
| RS (1) | RS50730B (is) |
| SI (1) | SI1322673T1 (is) |
| SK (2) | SK287218B6 (is) |
| TW (1) | TWI308153B (is) |
| UA (1) | UA79736C2 (is) |
| WO (1) | WO2002024754A1 (is) |
| ZA (1) | ZA200301692B (is) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2814463B1 (fr) * | 2000-09-22 | 2002-11-15 | Sanofi Synthelabo | Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine |
| FR2874924B1 (fr) * | 2004-09-09 | 2006-12-01 | Sanofi Aventis Sa | Hexadecasaccharides biotinyles, leur preparation et leur utilisation therapeutique |
| TWI403334B (zh) * | 2004-12-23 | 2013-08-01 | Merck Sharp & Dohme | 包含生物素殘基之抗血栓雙重抑制劑 |
| TWI376234B (en) * | 2005-02-01 | 2012-11-11 | Msd Oss Bv | Conjugates of a polypeptide and an oligosaccharide |
| ES2362011T3 (es) * | 2005-10-10 | 2011-06-27 | N.V. Organon | Inhibidores duales antitrombóticos anticoagulantes que comprenden una marca de biotina. |
| BRPI0617215A2 (pt) * | 2005-10-10 | 2011-07-19 | Organon Nv | composto anti-trombótico, composição farmacêutica, e, uso do composto |
| CN1317035C (zh) * | 2005-10-24 | 2007-05-23 | 天津大学 | 基于酰肼基的微粒表面多重生物功能因子组装方法 |
| EP1886696A1 (en) * | 2006-08-03 | 2008-02-13 | Endotis Pharma | Conjugates of antithrombin binding oligosaccharide derivatives and therapeutic proteins |
| FR2912409B1 (fr) * | 2007-02-14 | 2012-08-24 | Sanofi Aventis | Heparines de bas poids moleculaire comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine leur procede de preparation,leur utilisation |
| TW201006479A (en) * | 2008-07-18 | 2010-02-16 | Sanofi Aventis | Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment |
| EP2233143A1 (en) | 2009-03-24 | 2010-09-29 | Sanofi-Aventis | Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment |
| EP2145624A1 (en) | 2008-07-18 | 2010-01-20 | Sanofi-Aventis | Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment |
| FR2935386B1 (fr) | 2008-08-26 | 2010-09-10 | Sanofi Aventis | Nouveaux polysaccharides a activite antithrombotique comprenant une liaion covalente avec une chaine amine |
| EP2323605A4 (en) * | 2008-09-10 | 2014-02-05 | Syneron Medical Ltd | TRANSDERMAL RELEASE OF OLIGOSACCHARIDES |
| CA2746509C (en) | 2008-12-19 | 2018-11-20 | Supernus Pharmaceuticals, Inc. | Use of molindone for the treatment of impulsive agression |
| FR2952935B1 (fr) * | 2009-11-20 | 2011-12-02 | Sanofi Aventis | Procede de preparation du n-biotinyl-6-aminocaproate de n succinimidyle |
| AU2010332797B2 (en) | 2009-12-18 | 2015-05-28 | Catalent Pharma Solutions Gmbh | Pharmaceutical oral dosage form containing a synthetic oligosaccharide |
| CZ302669B6 (cs) * | 2010-03-29 | 2011-08-24 | Univerzita Palackého v Olomouci | Efektivní zpusob biotinylace aminosloucenin pomocí syntézy na pevné fázi pro potreby afinitní chromatografie |
| CZ302510B6 (cs) * | 2010-03-29 | 2011-06-22 | Univerzita Palackého v Olomouci | Efektivní zpusob biotinylace sloucenin s karboxylovou skupinou pomocí syntézy na pevné fázi pro potreby afinitní chromatografie |
| AU2011235222B2 (en) | 2010-03-31 | 2014-09-25 | Supernus Pharmaceuticals Inc. | Stabilized formulations of CNS compounds |
| FR2964660B1 (fr) * | 2010-09-10 | 2012-09-28 | Sanofi Aventis | Nouveaux polysaccharides biotinyles a activite antithrombotique et presentant une stabilite metabolique amelioree |
| JP2013537181A (ja) * | 2010-09-10 | 2013-09-30 | サノフイ | 抗血栓活性及び改善された代謝安定性を有するビオチン化多糖類 |
| EP2484366A1 (en) | 2011-02-07 | 2012-08-08 | Sanofi | Idrabiotaparinux for the treatment of pulmonary embolism and for the secondary prevention of venous thromboembolic events |
| ES2560467T3 (es) | 2011-06-17 | 2016-02-19 | Carbomimetics | Pentasacáridos sintéticos que tienen vida media corta y alta actividad |
| EP3524251A1 (en) * | 2012-11-13 | 2019-08-14 | Supernus Pharmaceuticals, Inc. | Method of treatment of aggression |
| WO2015195404A1 (en) | 2014-06-20 | 2015-12-23 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Methods for detection of an analyte by movement of tethered microparticles |
| WO2016205239A1 (en) | 2015-06-15 | 2016-12-22 | The United States Of America, As Represented By The Secretary Department Of Health And Human Services | Non-hormonal mammalian sperm decoy contraception based on the n-terminus of the zp2 protein |
| JP7492826B2 (ja) | 2016-10-21 | 2024-05-30 | ザ ユナイテッド ステイツ オブ アメリカ， アズ リプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ | 分子ナノタグ |
| CN108976318B (zh) * | 2017-06-01 | 2021-03-30 | 首都医科大学 | 单-6-(生物素酰胺基)-6-脱氧-β-环糊精及其制备方法和应用 |
| WO2019133727A1 (en) | 2017-12-29 | 2019-07-04 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Universal influenza virus probe set for enrichment of any influenza virus nucleic acid |
| BR112022000255A8 (pt) | 2019-07-09 | 2022-03-22 | Optimvia Llc | Métodos para sintetizar polissacarídeos anticoagulantes |
| WO2021075165A1 (ja) * | 2019-10-17 | 2021-04-22 | 株式会社オートネットワーク技術研究所 | 配線モジュール |
| WO2022056078A1 (en) | 2020-09-11 | 2022-03-17 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Rnase h-assisted detection assay for rna (radar) |
| WO2024191684A1 (en) | 2023-03-10 | 2024-09-19 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Detection of hepatitis c virus ribonucleic acid from whole blood using reverse transcription loop-mediated isothermal amplification |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3960884A (en) * | 1974-04-24 | 1976-06-01 | Sergei Ivanovich Zavyalov | Method of preparing racemic biotin |
| AU563351C (en) * | 1982-01-15 | 2003-06-19 | Glaxo Group Limited | Synthesis of oligosaccharides |
| IL102758A (en) * | 1991-08-23 | 1997-03-18 | Akzo Nv | Glycosaminoglycanoid derivatives, their preparation and pharmaceutical compositions comprising them |
| US20010023288A1 (en) * | 1999-07-07 | 2001-09-20 | Wilbur D. Scott | Trifunctional reagent for conjugation to a biomolecule |
| FR2751334B1 (fr) * | 1996-07-19 | 1998-10-16 | Sanofi Sa | Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant |
| FR2773801B1 (fr) * | 1998-01-19 | 2000-05-12 | Sanofi Sa | Nouveaux pentasaccharides, procedes pour leurs preparations et compositions pharmaceutiques les contenant |
| FR2773804B1 (fr) * | 1998-01-19 | 2000-02-18 | Sanofi Sa | Polysaccharides de synthese, procede pour leur preparation et compositions pharmaceutiques le contenant |
| GB2335490B (en) * | 1998-03-20 | 2003-05-14 | Ortho Clinical Diagnostics | An assay surface that permits an analyte releasiing step |
| AU8366398A (en) * | 1998-07-07 | 2000-01-24 | Department Of Radiation Oncology University Of Washington | Trifunctional reagent for conjugation to a biomolecule |
| WO2000006608A1 (fr) | 1998-07-31 | 2000-02-10 | Seikagaku Corporation | Nouveau glycosaminoglycan et compositions medicamenteuses le contenant |
| FR2814463B1 (fr) * | 2000-09-22 | 2002-11-15 | Sanofi Synthelabo | Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine |
-
2000
- 2000-09-22 FR FR0012094A patent/FR2814463B1/fr not_active Expired - Fee Related
-
2001
- 2001-09-20 HU HU0303551A patent/HUP0303551A3/hu not_active Application Discontinuation
- 2001-09-20 IL IL15484801A patent/IL154848A0/xx unknown
- 2001-09-20 ME MEP-2008-236A patent/ME00080B/me unknown
- 2001-09-20 CA CA2418815A patent/CA2418815C/en not_active Expired - Fee Related
- 2001-09-20 NZ NZ524472A patent/NZ524472A/en not_active IP Right Cessation
- 2001-09-20 KR KR1020087009747A patent/KR20080049139A/ko not_active Application Discontinuation
- 2001-09-20 EA EA200300237A patent/EA005133B1/ru not_active IP Right Cessation
- 2001-09-20 US US10/381,154 patent/US6844329B2/en not_active Expired - Lifetime
- 2001-09-20 SK SK5031-2009A patent/SK287218B6/sk not_active IP Right Cessation
- 2001-09-20 KR KR1020037004108A patent/KR100891388B1/ko not_active IP Right Cessation
- 2001-09-20 GE GE5103A patent/GEP20053616B/en unknown
- 2001-09-20 DE DE60130669T patent/DE60130669T2/de not_active Expired - Lifetime
- 2001-09-20 HU HUP1400034 patent/HU1400034D0/hu not_active Application Discontinuation
- 2001-09-20 ME MEP-236/08A patent/MEP23608A/xx unknown
- 2001-09-20 CZ CZ20030814A patent/CZ300856B6/cs not_active IP Right Cessation
- 2001-09-20 WO PCT/FR2001/002918 patent/WO2002024754A1/fr active Application Filing
- 2001-09-20 AU AU2001291960A patent/AU2001291960C1/en not_active Ceased
- 2001-09-20 RS YUP-197/03A patent/RS50730B/sr unknown
- 2001-09-20 JP JP2002529162A patent/JP5016778B2/ja not_active Expired - Fee Related
- 2001-09-20 SI SI200130786T patent/SI1322673T1/sl unknown
- 2001-09-20 DK DK01972171T patent/DK1322673T3/da active
- 2001-09-20 CN CNB018161588A patent/CN1235914C/zh not_active Expired - Fee Related
- 2001-09-20 PL PL363368A patent/PL206727B1/pl unknown
- 2001-09-20 EP EP01972171A patent/EP1322673B1/fr not_active Expired - Lifetime
- 2001-09-20 MX MXPA03002483A patent/MXPA03002483A/es active IP Right Grant
- 2001-09-20 SK SK356-2003A patent/SK287054B6/sk not_active IP Right Cessation
- 2001-09-20 UA UA2003021719A patent/UA79736C2/uk unknown
- 2001-09-20 AT AT01972171T patent/ATE374215T1/de active
- 2001-09-20 ES ES01972171T patent/ES2292625T3/es not_active Expired - Lifetime
- 2001-09-20 PT PT01972171T patent/PT1322673E/pt unknown
- 2001-09-20 AU AU9196001A patent/AU9196001A/xx active Pending
- 2001-09-20 EE EEP200300114A patent/EE05202B1/xx not_active IP Right Cessation
- 2001-09-20 AR ARP010104436A patent/AR030774A1/es not_active Application Discontinuation
- 2001-09-20 BR BR0114007-8A patent/BR0114007A/pt active Search and Examination
- 2001-09-21 TW TW090123340A patent/TWI308153B/zh not_active IP Right Cessation
- 2001-09-21 PE PE2001000952A patent/PE20020471A1/es not_active Application Discontinuation
-
2003
- 2003-02-28 IS IS6733A patent/IS2550B/is unknown
- 2003-02-28 ZA ZA200301692A patent/ZA200301692B/en unknown
- 2003-03-10 IL IL154848A patent/IL154848A/en not_active IP Right Cessation
- 2003-03-14 EC EC2003004514A patent/ECSP034514A/es unknown
- 2003-03-20 NO NO20031295A patent/NO332905B1/no not_active IP Right Cessation
- 2003-03-20 BG BG107650A patent/BG66191B1/bg unknown
- 2003-03-21 HR HR20030219A patent/HRP20030219B1/xx not_active IP Right Cessation
- 2003-08-05 HK HK03105615A patent/HK1053316A1/xx not_active IP Right Cessation
-
2005
- 2005-01-14 US US11/035,717 patent/US7943595B2/en not_active Expired - Fee Related
-
2007
- 2007-12-04 CY CY20071101542T patent/CY1108076T1/el unknown
-
2011
- 2011-02-28 US US13/036,143 patent/US8318696B2/en not_active Expired - Fee Related
- 2011-03-16 NO NO20110401A patent/NO20110401L/no not_active Application Discontinuation
-
2012
- 2012-02-10 JP JP2012027377A patent/JP2012131809A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1053316A1 (en) | Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative | |
| AU2001291960A1 (en) | Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative | |
| EP1191039A4 (en) | POLYSACCHARIDE DERIVATIVE | |
| PL355484A1 (en) | Antithrombotic compound | |
| GB9902598D0 (en) | A suspension arrangement | |
| GB9905055D0 (en) | A waste-treatable lubricant | |
| PL344721A1 (en) | Facing element incorporating a decorative portion | |
| GB2349434B (en) | A gearbox assembly | |
| GB0207861D0 (en) | A decorative article | |
| GB0008700D0 (en) | A shelf assembly | |
| GB9901266D0 (en) | A bookend | |
| GB9905988D0 (en) | A sock with open front | |
| AU138534S (en) | A side form connector assembly | |
| AU142198S (en) | A decorative article | |
| AU141556S (en) | A wormery assembly | |
| GB9926160D0 (en) | Antithrombotic agents | |
| AU141249S (en) | A lower body garment | |
| AU141085S (en) | A doll | |
| AU141061S (en) | A doll | |
| AU141062S (en) | A doll | |
| GB9906561D0 (en) | A linking bracket | |
| AU140989S (en) | A side form | |
| AU140968S (en) | A side form | |
| AU140967S (en) | A side form | |
| AU140988S (en) | A side form |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Change of ownership |
Owner name: SANOFI-SYNTHELABO Free format text: FORMER OWNER(S): SANOFI-SYNTHELABO, AKZO NOBEL N.V |
|
| CHPA | Change of a particular in the register (except of change of ownership) | ||
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20160920 |